Immunotherapy in the Management of Lung Cancer

Immunotherapy in the Management of Lung Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Détails bibliographiques
Auteur principal:	Tasnim, Humayra
Autres auteurs:	khan, Tanisha Tabassum Sayka
Format:	Thèse
Langue:	en_US
Publié:	Brac University 2022
Sujets:	Lung cancer Immunotherapy Cytokines Checkpoint inhibitors Adoptive cell therapy Vaccines Cancer > Treatment Cancer > Immunotherapy
Accès en ligne:	http://hdl.handle.net/10361/17515

Documents similaires

Current practice and approaches of immunotherapy in Cancer treatment
par: Khondokar, Faiza
Publié: (2022)

A review on targeted therapies for lung cancer
par: Ashraf, Anushey
Publié: (2023)

Immunotherapy in the treatment of renal cancer
par: Shimu, Sumaya
Publié: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
par: Ratu, Tabassum
Publié: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
par: Fred, Namanda Rogers
Publié: (2021)

A review paper on Nanotechnology based strategies in the treatment of cancer
par: Rahman, Samia
Publié: (2022)

CAR-T cell Therapy in B-cell Lymphoma
par: Faruk, Asef
Publié: (2020)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Flora, Sanzida Alam
Publié: (2024)

Dendritic cell vaccine for the treatment of cancer
par: Haque, Tanzila
Publié: (2023)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
par: Abir, Shifaty Nur
Publié: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
par: Bristy, Israt Zerin
Publié: (2021)

Role of toll-like receptors in cancer immunotherapy– a review
par: Khan, Rezia Nowrin
Publié: (2021)

Stem cell in cancer disease cure vs cause
par: Chowdhury, Marisha Mansur
Publié: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
par: Jahan, Nusrat
Publié: (2024)

Molecules associated with the development of lung cancer
par: Rahman, Adree, et autres
Publié: (2023)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
par: Rahman, Sanjida
Publié: (2024)

Potential of liposomes for the treatment of lung cancer- a review
par: Mim, Shanzida
Publié: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
par: Rahman, Tasnim
Publié: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
par: Tania, Umme
Publié: (2023)

A review on recent advances in drugs for lung cancer treatment
par: Noor, Fouzia
Publié: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
par: Jeba, Joynob
Publié: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
par: Razna, Amrin Islam
Publié: (2019)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
par: Meem, Manila
Publié: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
par: Islam, Saidul
Publié: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
par: Pial, Sazia Afrin
Publié: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
par: Paul, Pulock
Publié: (2024)

Stem cells as therapeutic carrier in cancer treatment
par: Anika, Mysha Yeasmin
Publié: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
par: Emon, Kamrul Hasan
Publié: (2022)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
par: Shabnam, Musharrat
Publié: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
par: Zangmo, Thinley
Publié: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
par: Hoque, Ismoth Ara
Publié: (2024)

A comprehensive review on drug repurposing in cancer treatment
par: Sarkar, Onusree
Publié: (2024)

Lung cancer detection and classification using machine learning
par: Arefin, Mahbubul, et autres
Publié: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
par: Nandy, Aditi
Publié: (2022)

Targeted therapeutic options in the treatment of Breast Cancer
par: Alam, Kazi Tasnuva
Publié: (2022)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
par: Pecorino, Lauren
Publié: (2012)

Statistics and informatics in molecular cancer research

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
par: Khan, Muidul Hasan
Publié: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
par: Kamal, Tasnova
Publié: (2019)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
par: Hasan, Amit
Publié: (2024)